Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.

Orphanet J Rare Dis · 2019 · PMC6360670 · PMID 30717761

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significancep value > 0.1so close (0.05 < p ≤ 0.1)

The trends for number and severity of AEs with either BZB and TH across grades 1–5 did not reach statistical significance ( p value > 0.1).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.